Anna Devor.

Anna Devor

Professor of biomedical engineering
Boston University

Anna Devor is professor of biomedical engineering at Boston University (BU), associate director of the BU Neurophotonics Center, and editor-in-chief of the journal Neurophotonics, published by the optical engineering society SPIE.

Devor’s lab, the Neurovascular Imaging Laboratory, specializes in imaging neuronal, glial, vascular and metabolic activity in the brains of living and behaving experimental animals. Her research is focused on understanding fundamental neurovascular and neurometabolic principles of brain activity and the mechanistic underpinning of noninvasive brain imaging signals. She also works on imaging of stem-cell-derived human neuronal networks.

Devor received her Ph.D. in neuroscience from the Hebrew University of Jerusalem. After completing her postdoctoral training in neuroimaging at the Athinoula A. Martinos Center for Biomedical Imaging, she established her own lab at the University of California, San Diego before moving it to BU in 2020. She has a wide network of collaborators across the world and is experienced in leading large, multidisciplinary teams.

Explore more from The Transmitter

A human arm and a robot arm write code together on a small blackboard.

How to teach programming in the age of AI

Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.

By Ashley Juavinett
30 March 2026 | 8 min read
A blue comment bubble is pinned down by crisscrossing red threads and pins.

Neuroscience conference policy draws confusion, apology

NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.

By Dalmeet Singh Chawla
27 March 2026 | 5 min read
Assembloids in a petri dish.

Funding for animal research alternatives reaches ‘inflection point’

The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.

By Claudia López Lloreda
26 March 2026 | 4 min read